Coronin 1-mediated naive T cell survival is essential for the development of autoimmune encephalomyelitis

Journal of Immunology

Volumn 186, Issue 6, 2011, Pages 3452-3461

  Siegmund, Kerstin ^a   Zeis, Thomas ^b   Kunz, Gabriele ^a   Rolink, Ton ^b   Schaeren Wiemers, Nicole ^b   Pieters, Jean ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; CORONIN 1; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; DISEASE RESISTANCE; FEMALE; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES, T-LYMPHOCYTE; FEMALE; G0 PHASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; MYELIN BASIC PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 79953228877     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003491     Document Type: Article

References (46)

1. Compston, A., and A. Coles. 2002. Multiple sclerosis. Lancet 359: 1221-1231.
2. Gold, R., C. Linington, and H. Lassmann. 2006. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129: 1953-1971.
3. Iglesias, A., J. Bauer, T. Litzenburger, A. Schubart, and C. Linington. 2001. Tand B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36: 220-234.
4. Kivisäkk, P., J. Imitola, S. Rasmussen, W. Elyaman, B. Zhu, R. M. Ransohoff, and S. J. Khoury. 2009. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann. Neurol. 65: 457-469.
5. Greter, M., F. L. Heppner, M. P. Lemos, B. M. Odermatt, N. Goebels, T. Laufer, R. J. Noelle, and B. Becher. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11: 328-334.
6. Stromnes, I. M., L. M. Cerretti, D. Liggitt, R. A. Harris, and J. M. Goverman. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 14: 337-342.
7. Kroenke, M. A., T. J. Carlson, A. V. Andjelkovic, and B. M. Segal. 2008. IL-12-and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205: 1535-1541.
8. Cua, D. J., and S. A. Stohlman. 1997. In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets. J. Immunol. 159: 5834-5840.
9. Falcone, M., and B. R. Bloom. 1997. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185: 901-907.
10. Kohm, A. P., P. A. Carpentier, H. A. Anger, and S. D. Miller. 2002. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
11. Reddy, J., Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, L. Nicholson, R. A. Sobel, K. W. Wucherpfennig, and V. K. Kuchroo. 2004. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 101: 15434-15439.
12. Stephens, L. A., K. H. Malpass, and S. M. Anderton. 2009. Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg. Eur. J. Immunol. 39: 1108-1117.
13. McGeachy, M. J., L. A. Stephens, and S. M. Anderton. 2005. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+ CD25+ regulatory cells within the central nervous system. J. Immunol. 175: 3025-3032.
14. Boyman, O., S. Létourneau, C. Krieg, and J. Sprent. 2009. Homeostatic proliferation and survival of naïve and memory T cells. Eur. J. Immunol. 39: 2088-2094.
15. Tanchot, C., F. A. Lemonnier, B. Pérarnau, A. A. Freitas, and B. Rocha. 1997. Differential requirements for survival and proliferation of CD8 naïve or memory T cells. Science 276: 2057-2062.
16. Kirberg, J., A. Berns, and H. von Boehmer. 1997. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J. Exp. Med. 186: 1269-1275.
17. Martin, B., C. Bécourt, B. Bienvenu, and B. Lucas. 2006. Self-recognition is crucial for maintaining the peripheral CD4+ T-cell pool in a nonlymphopenic environment. Blood 108: 270-277.
18. Polic, B., D. Kunkel, A. Scheffold, and K. Rajewsky. 2001. How alpha beta T cells deal with induced TCR alpha ablation. Proc. Natl. Acad. Sci. USA 98: 8744-8749.
19. Föger, N., L. Rangell, D. M. Danilenko, and A. C. Chan. 2006. Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis. Science 313: 839-842.
20. Mueller, P., J. Massner, R. Jayachandran, B. Combaluzier, I. Albrecht, J. Gatfield, C. Blum, R. Ceredig, H. R. Rodewald, A. G. Rolink, and J. Pieters. 2008. Regulation of T cell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering. Nat. Immunol. 9: 424-431.
21. Haraldsson, M. K., C. A. Louis-Dit-Sully, B. R. Lawson, G. Sternik, M. L. Santiago-Raber, N. R. Gascoigne, A. N. Theofilopoulos, and D. H. Kono. 2008. The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. Immunity 28: 40-51.
22. Shiow, L. R., D. W. Roadcap, K. Paris, S. R. Watson, I. L. Grigorova, T. Lebet, J. An, Y. Xu, C. N. Jenne, N. Föger, et al. 2008. The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency. Nat. Immunol. 9: 1307-1315.
23. Mugnier, B., B. Nal, C. Verthuy, C. Boyer, D. Lam, L. Chasson, V. Nieoullon, G. Chazal, X. J. Guo, H. T. He, et al. 2008. Coronin-1A links cytoskeleton dynamics to TCR alpha beta-induced cell signaling. PLoS ONE 3: e3467.
24. Combaluzier, B., P. Mueller, J. Massner, D. Finke, and J. Pieters. 2009. Coronin 1 is essential for IgM-mediated Ca2+ mobilization in B cells but dispensable for the generation of immune responses in vivo. J. Immunol. 182: 1954-1961.
25. Jayachandran, R., V. Sundaramurthy, B. Combaluzier, P. Mueller, H. Korf, K. Huygen, T. Miyazaki, I. Albrecht, J. Massner, and J. Pieters. 2007. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell 130: 37-50.
26. Linker, R. A., M. Mäurer, S. Gaupp, R. Martini, B. Holtmann, R. Giess, P. Rieckmann, H. Lassmann, K. V. Toyka, M. Sendtner, and R. Gold. 2002. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8: 620-624.
27. Becher, B., B. G. Durell, A. V. Miga, W. F. Hickey, and R. J. Noelle. 2001. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 193: 967-974.
28. Harlow, E. 1989. Antibodies: A Laboratory Manual. Cold Spring Harbor Press, Cold Spring Harbor, NY.
29. Storch, M. K., A. Stefferl, U. Brehm, R. Weissert, E. Wallström, M. Kerschensteiner, T. Olsson, C. Linington, and H. Lassmann. 1998. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8: 681-694.
30. Weissert, R., E. Wallström, M. K. Storch, A. Stefferl, J. Lorentzen, H. Lassmann, C. Linington, and T. Olsson. 1998. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 102: 1265-1273.
31. Austyn, J. M., and S. Gordon. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11: 805-815.
32. Gatfield, J., I. Albrecht, B. Zanolari, M. O. Steinmetz, and B. Pieters. 2005. Association of the leukocyte plasma membrane with the actin cytoskeleton through coiled coil-mediated trimeric coronin 1 molecules. Mol. Biol. Cell 16: 786-2798.
33. O'Connor, R. A., and S. M. Anderton. 2008. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 193: 1-11.
34. Goverman, J. 2009. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9: 393-407.
35. Seamons, A., A. Perchellet, and J. Goverman. 2003. Immune tolerance to myelin proteins. Immunol. Res. 28: 201-221.
36. Hogquist, K. A. 2008. Immunodeficiency: when T cells are stuck at home. Nat. Immunol. 9: 1207-1208.
37. Shi, Y., Y. Feng, J. Kang, C. Liu, Z. Li, D. Li, W. Cao, J. Qiu, Z. Guo, E. Bi, et al. 2007. Critical regulation of CD4+ T cell survival and autoimmunity by betaarrestin1. Nat. Immunol. 8: 817-824.
38. Jayachandran, R., J. Gatfield, J. Massner, I. Albrecht, B. Zanolari, and J. Pieters. 2008. RNA interference in J774 macrophages reveals a role for coronin 1 in mycobacterial trafficking but not in actin-dependent processes. Mol. Biol. Cell 19: 1241-1251.
39. Davalos-Misslitz, A. C., J. Rieckenberg, S. Willenzon, T. Worbs, E. Kremmer, G. Bernhardt, and R. Förster. 2007. Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur. J. Immunol. 37: 613-622.
40. Greter, M., J. Hofmann, and B. Becher. 2009. Neo-lymphoid aggregates in the adult liver can initiate potent cell-mediated immunity. PLoS Biol. 7: e1000109.
41. Uboldi, C., A. Döring, C. Alt, P. Estess, M. Siegelman, and B. Engelhardt. 2008. L-Selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 38: 2156-2167.
42. Carrithers, M. D., I. Visintin, S. J. Kang, and C. A. Janeway, Jr. 2000. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 123: 1092-1101.
43. Reboldi, A., C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, S. Lira, A. Uccelli, A. Lanzavecchia, B. Engelhardt, and F. Sallusto. 2009. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10: 514-523.
44. Brostoff, S. W., and D. W. Mason. 1984. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J. Immunol. 133: 1938-1942.
45. Waldor, M. K., S. Sriram, R. Hardy, L. A. Herzenberg, L. A. Herzenberg, L. Lanier, M. Lim, and L. Steinman. 1985. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science 227: 415-417.
46. Waldor, M. K., D. Mitchell, T. J. Kipps, L. A. Herzenberg, and L. Steinman. 1987. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody. J. Immunol. 139: 3660-3664.